{"nct_id":"NCT04447469","title":"Study of Mavrilimumab (KPL-301) in Participants Hospitalized With Severe Corona Virus Disease 2019 (COVID-19) Pneumonia and Hyper-inflammation","status":"COMPLETED","status_verified_date":"2024-12","start_date":"2020-07-28","start_date_type":"ACTUAL","primary_completion_date":"2021-11-12","primary_completion_date_type":"ACTUAL","completion_date":"2022-01-14","completion_date_type":"ACTUAL","phases":["PHASE2","PHASE3"],"tickers":["KNSA"]}